This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • ROMAZA: Phase I trial of combination therapy with ...
Clinical trial

ROMAZA: Phase I trial of combination therapy with romidepsin and azacitidine in patients with newly diagnosed, relapsed or refractory Acute Myeloid Leukaemia ineligible for conventional chemotherapy

Read time: 1 mins
Last updated:14th May 2013
To determine the maximum tolerated dose of Azacitidine in combination with Romidepsin
Category Value
Study start date 2013-05-14

View full details